AnalystBook Research · Company Intelligence

Cohen & Co Inc.

COHNNYSE

Built from Cohen & Co Inc.'s own SEC filings · updates as new filings land · sources cited throughout

or browse all covered companies

Revenue increased 246.2% to $275.6M, while Net income increased 11286.8% to $14.4M.

The read at a glance✓ Audited against SEC data
  • EarningsFY2025 net income $14.4MOK
  • ProfitabilityNet income $14.4MOK
  • Balance-sheet lensCredit, capital, funding and liquidityOK
  • AccountingNo applicable forensic screenNote
  • Insiders1 buys; 2 sells in 365 daysOK
  • Capitaldividends paid were $2.1MNote

Business

Cohen & Co Inc.: Our Capital Markets business segment consists of sales, trading, gestation repo financing, new issue placements in corporate and securitized products, underwriting, and advisory services, operating primarily through our subsidiaries, Cohen Securities in the United States (the "U.S.") and CCFESA in Europe.

Where the revenue comes from

Fiscal 2025, as Cohen & Co Inc. reports it. History and quarterly detail are in the app.

  • Capital Markets$235.0M
  • Principal Investing$30.0M
  • Asset Management$10.6M

Latest filings

  • 8-K · Company announcement2026-08-31
  • 8-K · Company announcement2026-08-03
  • 10-Q · Quarterly report2026-08-03
  • 8-K · Company announcement2026-07-10
  • 8-K · Company announcement2026-06-30
In the full recordFree for 14 days
  • What changed🔒
  • Insider signal🔒
  • Growth quality🔒
  • Margins & accounting🔒
  • Capital allocation🔒
  • Real risks🔒
  • The long arc🔒
  • Company history🔒
  • The filings, readable — with what changed vs the prior year highlighted🔒
  • Full financial statements, industry-aware, sources cited throughout🔒
  • Forensic score history & components — the trend, not one year🔒
  • Ownership: insider buys/sells, clusters, activist stakes🔒
  • Ana — ask about Cohen & Co Inc., every answer cited to the official filings🔒

Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.

14-day free trial, no credit card. For research purposes only; not investment advice.